Comparison of 100-day mortality rates associated with i.v. busulfan and cyclophosphamide vs other preparative regimens in allogeneic bone marrow transplantation for chronic myelogenous leukemia: Bayesian sensitivity analyses of confounded treatment (Q94369221)

From Wikidata

Jump to navigation Jump to search

scientific article published in June 2004

Language	Label	Description	Also known as
English	Comparison of 100-day mortality rates associated with i.v. busulfan and cyclophosphamide vs other preparative regimens in allogeneic bone marrow transplantation for chronic myelogenous leukemia: Bayesian sensitivity analyses of confounded treatment	scientific article published in June 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15122310%20AND%20SRC:MED&resulttype=core&format=json

14 May 2020

Comparison of 100-day mortality rates associated with i.v. busulfan and cyclophosphamide vs other preparative regimens in allogeneic bone marrow transplantation for chronic myelogenous leukemia: Bayesian sensitivity analyses of confounded treatment and center effects (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15122310%20AND%20SRC:MED&resulttype=core&format=json

14 May 2020

Richard E Champlin

2

object named as

Champlin RE

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15122310%20AND%20SRC:MED&resulttype=core&format=json

14 May 2020

author name string

Thall PF

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15122310%20AND%20SRC:MED&resulttype=core&format=json

14 May 2020

Andersson BS

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15122310%20AND%20SRC:MED&resulttype=core&format=json

14 May 2020

publication date

1 June 2004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15122310%20AND%20SRC:MED&resulttype=core&format=json

14 May 2020

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15122310%20AND%20SRC:MED&resulttype=core&format=json

14 May 2020

33

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15122310%20AND%20SRC:MED&resulttype=core&format=json

14 May 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15122310%20AND%20SRC:MED&resulttype=core&format=json

14 May 2020

1191-1199

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15122310%20AND%20SRC:MED&resulttype=core&format=json

14 May 2020

Bone marrow transplantation for pediatric leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704461

7 January 2021

based on heuristic

inferred from DOI database lookup

Late effects of intensive treatment for acute myeloid leukemia and myelodysplasia in childhood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704461

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicities of total-body irradiation for pediatric bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704461

7 January 2021

based on heuristic

inferred from DOI database lookup

Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704461

7 January 2021

based on heuristic

inferred from DOI database lookup

New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704461

7 January 2021

based on heuristic

inferred from DOI database lookup

Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704461

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704461

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic and metabolic studies of high-dose busulphan in adults

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704461

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute safety and pharmacokinetics of intravenous busulfan when used with oral busulfan and cyclophosphamide as pretransplantation conditioning therapy: a phase I study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704461

7 January 2021

based on heuristic

inferred from DOI database lookup

Formulation and stability of busulfan for intravenous administration in high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704461

7 January 2021

based on heuristic

inferred from DOI database lookup

Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase II study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704461

7 January 2021

based on heuristic

inferred from DOI database lookup

Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: defining a therapeutic window for i.v. BuCy2 in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704461

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemtuzumab ozogamicin with or without interleukin 11 in patients 65 years of age or older with untreated acute myeloid leukemia and high-risk myelodysplastic syndrome: comparison with idarubicin plus continuous-infusion, high-dose cytosine arabinosi

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704461

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704461

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic blood stem cell transplantation in advanced hematologic cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704461

7 January 2021

based on heuristic

inferred from DOI database lookup

Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704461

7 January 2021

based on heuristic

inferred from DOI database lookup

Carmustine, etoposide, cytarabine and melphalan as a preparative regimen for allogeneic transplantation for high-risk malignant lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704461

7 January 2021

based on heuristic

inferred from DOI database lookup

Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704461

7 January 2021

based on heuristic

inferred from DOI database lookup

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704461

7 January 2021

based on heuristic

inferred from DOI database lookup

HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704461

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1704461

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15122310%20AND%20SRC:MED&resulttype=core&format=json

14 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15122310%20AND%20SRC:MED&resulttype=core&format=json

14 May 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q94369221&oldid=1809631773"